{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:03:42Z","timestamp":1780470222651,"version":"3.54.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sweet syndrome (SS), also known as acute febrile neutrophilic dermatosis, is an immunologic syndrome characterized by widespread neutrophilic infiltration. Histiocytoid Sweet syndrome (H-SS) is a histopathologic variant of SS. While SS most commonly occurs in adults, this case report discusses an infant patient who presented with H-SS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>Through a multidisciplinary approach, this patient was also found to have very early onset inflammatory bowel disease (VEO-IBD) and Mevalonate kinase-associated disease (MKAD). While prior case studies have characterized an association between VEO-IBD and MKAD, there is no literature describing the association of all three diagnoses this case: H-SS, VEO-IBD and MKAD. Initiation of canakinumab in this patient resulted in successful control of the disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This case highlights the importance of a multidisciplinary approach to rare diagnoses, and collaboration during cases with significant diagnostic uncertainty.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12969-023-00887-8","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T06:02:46Z","timestamp":1694498566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A case of neonatal sweet syndrome associated with mevalonate kinase deficiency"],"prefix":"10.1186","volume":"21","author":[{"given":"Margaret","family":"Irwin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veeraya K.","family":"Tanawattanacharoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Beth F.","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca C.","family":"Hale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig D.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Putra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitta A.R.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mollie G.","family":"Wasserman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,12]]},"reference":[{"key":"887_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1750-1172-2-34","volume":"2","author":"PR Cohen","year":"2007","unstructured":"Cohen PR. Sweet\u2019s syndrome\u2013a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis. 2007;2:34.","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"887_CR2","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1001\/archderm.141.7.834","volume":"141","author":"L Requena","year":"2005","unstructured":"Requena L, et al. Histiocytoid Sweet syndrome: a dermal infiltration of immature neutrophilic granulocytes. Arch Dermatol. 2005;141(7):834\u201342.","journal-title":"Arch Dermatol"},{"issue":"1","key":"887_CR3","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jaad.2014.09.025","volume":"72","author":"A Peroni","year":"2015","unstructured":"Peroni A, et al. Histiocytoid Sweet syndrome is infiltrated predominantly by M2-like macrophages. J Am Acad Dermatol. 2015;72(1):131\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"887_CR4","doi-asserted-by":"publisher","first-page":"e1353","DOI":"10.1542\/peds.2011-1854","volume":"129","author":"PEA Gray","year":"2012","unstructured":"Gray PEA, et al. Neonatal Sweet Syndrome: a potential marker of serious systemic illness. Pediatrics. 2012;129(5):e1353\u20139.","journal-title":"Pediatrics"},{"issue":"1","key":"887_CR5","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1067\/mjd.2003.328","volume":"49","author":"K Parsapour","year":"2003","unstructured":"Parsapour K, et al. Familial Sweet\u2019s syndrome in 2 brothers, both seen in the first 2 weeks of life. J Am Acad Dermatol. 2003;49(1):132\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"887_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2147\/TACG.S93933","volume":"9","author":"LA Favier","year":"2016","unstructured":"Favier LA, Schulert GS. Mevalonate kinase deficiency: current perspectives. Appl Clin Genet. 2016;9:101\u201310.","journal-title":"Appl Clin Genet"},{"issue":"2","key":"887_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/9691","volume":"22","author":"SM Houten","year":"1999","unstructured":"Houten SM, et al. Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome. Nat Genet. 1999;22(2):175\u20137.","journal-title":"Nat Genet"},{"issue":"1","key":"887_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1750-1172-1-13","volume":"1","author":"D Haas","year":"2006","unstructured":"Haas D, Hoffmann GF. Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome. Orphanet J Rare Dis. 2006;1(1):13.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"887_CR9","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1542\/peds.91.5.915","volume":"91","author":"GF Hoffmann","year":"1993","unstructured":"Hoffmann GF, et al. Clinical and biochemical phenotype in 11 patients with mevalonic aciduria. Pediatrics. 1993;91(5):915\u201321.","journal-title":"Pediatrics"},{"issue":"6","key":"887_CR10","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1093\/ibd\/izz259","volume":"26","author":"J Ouahed","year":"2020","unstructured":"Ouahed J, et al. Very early onset inflammatory bowel disease: a clinical Approach with a focus on the role of Genetics and underlying Immune deficiencies. Inflamm Bowel Dis. 2020;26(6):820\u201342.","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"887_CR11","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1093\/ibd\/izab139","volume":"27","author":"B Bader-Meunier","year":"2021","unstructured":"Bader-Meunier B, et al. Mevalonate kinase Deficiency: a cause of severe very-early-onset inflammatory bowel disease. Inflamm Bowel Dis. 2021;27(11):1853\u20137.","journal-title":"Inflamm Bowel Dis"},{"issue":"Suppl 1","key":"887_CR12","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.4103\/2229-5178.171059","volume":"6","author":"S Pace","year":"2015","unstructured":"Pace S, Bingham J, Royer M. Histopathologic features in a case of hyperimmunoglobulinemia D syndrome. Indian Dermatol Online J. 2015;6(Suppl 1):S33\u20136.","journal-title":"Indian Dermatol Online J"},{"issue":"1","key":"887_CR13","doi-asserted-by":"publisher","first-page":"e000196","DOI":"10.1136\/rmdopen-2015-000196","volume":"2","author":"L Messer","year":"2016","unstructured":"Messer L, et al. Homozygosity for the V377I mutation in mevalonate kinase causes distinct clinical phenotypes in two sibs with hyperimmunoglobulinaemia D and periodic fever syndrome (HIDS). RMD Open. 2016;2(1):e000196.","journal-title":"RMD Open"},{"key":"887_CR14","doi-asserted-by":"crossref","unstructured":"Schlabe S et al. Hyper-IgD and periodic fever syndrome (HIDS) due to compound heterozygosity for G336S and V377I in a 44-year-old patient with a 27-year history of fever BMJ Case Rep, 2016. 2016.","DOI":"10.1136\/bcr-2016-217616"},{"issue":"2","key":"887_CR15","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/sj.ejhg.5200933","volume":"11","author":"SM Houten","year":"2003","unstructured":"Houten SM, et al. Carrier frequency of the V377I (1129G > A) MVK mutation, associated with Hyper-IgD and periodic fever syndrome, in the Netherlands. Eur J Hum Genet. 2003;11(2):196\u2013200.","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"887_CR16","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/sj.ejhg.5200614","volume":"9","author":"L Cuisset","year":"2001","unstructured":"Cuisset L, et al. Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome. Eur J Hum Genet. 2001;9(4):260\u20136.","journal-title":"Eur J Hum Genet"},{"key":"887_CR17","doi-asserted-by":"crossref","unstructured":"Munoz MA et al. Defective Protein Prenylation in a Spectrum of Patients With Mevalonate Kinase Deficiency Front Immunol, 2019. 10: p.\u00a01900.","DOI":"10.3389\/fimmu.2019.01900"},{"issue":"8","key":"887_CR18","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1002\/art.40146","volume":"69","author":"JI Arostegui","year":"2017","unstructured":"Arostegui JI, et al. Open-Label, phase II study to assess the efficacy and safety of Canakinumab treatment in active hyperimmunoglobulinemia D with periodic fever syndrome. Arthritis Rheumatol. 2017;69(8):1679\u201388.","journal-title":"Arthritis Rheumatol"},{"issue":"20","key":"887_CR19","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1056\/NEJMoa1706314","volume":"378","author":"F De Benedetti","year":"2018","unstructured":"De Benedetti F, et al. Canakinumab for the treatment of Autoinflammatory recurrent fever syndromes. N Engl J Med. 2018;378(20):1908\u201319.","journal-title":"N Engl J Med"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-023-00887-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-023-00887-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-023-00887-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T10:29:20Z","timestamp":1700389760000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-023-00887-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,12]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["887"],"URL":"https:\/\/doi.org\/10.1186\/s12969-023-00887-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2917831\/v1","asserted-by":"object"}]},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,12]]},"assertion":[{"value":"10 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No formal ethics approval was done for this case report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"for Publication: Written informed consent was obtained from the patient to publish this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"101"}}